| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.2 | 0.0009 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0009 |